Hemo Organic Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Operating Revenue	24.16	24.14	0.22	0.05	0.07	0.08
Other Revenue	0.72	0.7	0	-	-	-
Revenue	24.88	24.84	0.23	0.05	0.07	0.08
Revenue Growth (YoY)	11008.04%	10892.03%	370.83%	-29.72%	-15.37%	-97.09%
Cost of Revenue	22.01	22	0.15	0.02	0.09	0.04
Gross Profit	2.87	2.85	0.07	0.03	-0.02	0.04
Selling, General & Admin	0.79	0.38	0.4	-	0.36	0.39
Other Operating Expenses	1.72	2.22	2.04	0.58	0.24	0.13
Operating Expenses	2.51	2.59	2.44	0.58	0.6	0.51
Operating Income	0.36	0.26	-2.37	-0.55	-0.62	-0.48
Interest Expense	-0	-0	-0.2	-	-0	-0
EBT Excluding Unusual Items	0.36	0.26	-2.57	-0.55	-0.62	-0.48
Pretax Income	0.36	0.26	-2.57	-0.55	-0.62	-0.48
Income Tax Expense	-0.67	-1.38	0.07	-	-	-
Net Income	1.03	1.64	-2.64	-0.55	-0.62	-0.48
Net Income to Common	1.03	1.64	-2.64	-0.55	-0.62	-0.48
Shares Outstanding (Basic)	3	3	3	3	3	3
Shares Outstanding (Diluted)	3	3	3	3	3	3
Shares Change (YoY)	-2.88%	-	-	-	-	-4.72%
EPS (Basic)	0.30	0.47	-0.76	-0.16	-0.18	-0.14
EPS (Diluted)	0.30	0.47	-0.76	-0.16	-0.18	-0.14
Free Cash Flow	-	-3.62	-11.91	1.07	-0.04	-0.14
Free Cash Flow Per Share	-	-1.04	-3.44	0.31	-0.01	-0.04
Gross Margin	11.54%	11.46%	32.30%	66.67%	-36.47%	44.25%
Operating Margin	1.44%	1.03%	-1047.79%	-1137.50%	-911.63%	-593.02%
Profit Margin	4.14%	6.60%	-1168.58%	-1137.50%	-913.15%	-593.22%
Free Cash Flow Margin	-	-14.56%	-5267.70%	2231.25%	-64.85%	-170.58%
EBIT	0.36	0.26	-2.37	-0.55	-0.62	-0.48
EBIT Margin	1.44%	1.03%	-	-	-	-
Revenue as Reported	24.88	24.84	0.23	0.05	0.07	0.08
Advertising Expenses	-	0.03	0	-	-	0.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.